从外资调研标的来看，华明装备、影石创新和汇川技术位于外资调研榜前三位。此外，奥普特、怡合 达、安集科技、华润微、思特威等公司均吸引了超过20家外资机构前来调研。由此可见，外资调研主要 聚焦半导体、机器人等领域。 进入2026年，外资机构调研A股热情不减。Wind资讯数据显示，截至2月9日，年内已有224家外资机构 合计调研A股上市公司569次，其中包括摩根士丹利、贝莱德、高盛、花旗等知名外资机构。 此外，多家外资机构近日发布研报看好中国股市。例如，高盛维持中国股票"高配"评级，并预测中国指 数与沪深300指数将分别上涨20%和12%。瑞银表示，对中国股票持"具吸引力"观点，今年MSCI中国指 数的盈利增速预期将由去年的2.5%大幅反弹至13.6%，主要由科技股带动。 谈及中国股市的投资机会，马磊认为，一是产业升级。电动汽车、制药及自动化等关键行业有望推动下 一阶段的增长。拥有稳健研发实力的公司能够把握市场对先进产品及解决方案的需求。二是人工智能趋 势。2025年初发布的DeepSeek表明中国有能力提供兼具成本效益与高性能的大型语言模型，也标志着 中国已成为全球AI赛道一个强有力的竞争者。中国拥有全世界最大的 ...

Investment Rating - The report provides an "Outperform" rating for multiple companies in the healthcare sector, including BeiGene, JD Health, WuXi Biologics, and others, indicating a positive outlook for these stocks [1]. Core Insights - The macro and industry environment is improving due to the resolution of policy uncertainties, the release of significant clinical data, and a resurgence in global M&A activity, leading to a notable increase in investor sentiment towards innovative drugs for 2026 [4][11]. - In oncology, the PD-1/VEGF dual antibody approach is transitioning from "mechanism validation" to "clinical and industrial resonance," with multiple global Phase III trials underway, expected to catalyze approvals and data releases within the year [5][17]. - The metabolic sector is seeing growth in the cash-pay market for GLP-1 drugs, driven by limited insurance coverage and high out-of-pocket costs, prompting companies to enhance accessibility through direct sales and pricing adjustments [6][25]. - In the autoimmune space, there is a growing concentration risk among major products from multinational corporations (MNCs), with new antibody platforms expected to yield significant data in 2026, potentially leading to new business development opportunities [7]. - The central nervous system (CNS) investment focus remains on advancing Aβ monoclonal antibody treatments, with key data expected to open up early intervention market opportunities [9]. Summary by Sections Oncology - The PD-1/VEGF dual antibody's clinical and industrial certainty is strengthening, with major companies conducting multiple global Phase III trials across high-value indications [17]. - The Pan-RAS precision therapy is entering a realization phase, with key Phase III data expected in 2026 for pancreatic cancer and NSCLC [22]. Metabolic - The cash-pay market for GLP-1 drugs is expanding due to limited insurance coverage, with companies like Eli Lilly and Novo Nordisk adopting different direct-to-consumer strategies to enhance accessibility [25][26]. - Small nucleic acid therapies are expected to upgrade treatment paradigms, showing competitive data in weight loss and safety profiles when combined with GLP-1 [30]. Autoimmune - MNCs are increasingly reliant on a few blockbuster products, with structural opportunities arising from new antibody platforms expected to report data in 2026 [7]. - The trend towards oral formulations in autoimmune diseases is gaining traction, offering advantages in adherence and competitive differentiation [7]. CNS - The focus in CNS remains on Aβ monoclonal antibody treatments, with advancements expected to shift treatment towards earlier intervention populations [9]. - New delivery methods, such as systemic administration of small nucleic acids, are being explored as complementary approaches [9].

Investment Rating - The report maintains a "Buy" rating for the companies mentioned, including Weike Technology (301196.SZ), Nengke Technology (603859.SH), Hehe Information (688615.SH), and Maixinlin (688685.SH) [9][59]. Core Insights - The AI agent platform Moltbook has sparked significant industry interest, attracting over 1.5 million AI agents within days of its launch, indicating a strong growth potential for agent networks and associated infrastructure needs [3][23]. - DeepSeek-OCR2 has introduced a groundbreaking "causal flow" reasoning mechanism, significantly enhancing visual language understanding and achieving state-of-the-art results in benchmark tests [33][41]. - Poetiq has successfully completed a $45.8 million seed round, aiming to optimize LLM capabilities and cost efficiency, showcasing a shift towards more efficient AI solutions [45][46]. Summary by Sections Computing Power Dynamics - The rental prices for computing power remain stable, with notable configurations such as Tencent Cloud's A100-40G priced at 28.64 CNY/hour and Alibaba Cloud's A100-40G at 31.58 CNY/hour [21][22]. - The launch of Moltbook has led to a surge in agent network discussions, with over 52,000 posts and 230,000 comments generated by AI agents discussing various technical topics [23][30]. AI Application Dynamics - Kimi's weekly traffic increased by 40.89%, indicating strong user engagement in the AI application space [31][32]. - DeepSeek-OCR2's innovative architecture allows for improved document understanding, achieving a score of 91.09% in benchmark tests, which is a 3.73% improvement over its predecessor [41][43]. AI Financing Trends - Poetiq's seed funding will be utilized to advance its core technology, which has already demonstrated superior performance in benchmark tests compared to major competitors [45][46]. - The company’s unique approach allows for efficient problem-solving with minimal training data, marking a significant advancement in AI technology [46][47]. Investment Recommendations - The report emphasizes the high certainty of the AI sector, particularly in hardware and application segments, and suggests focusing on companies like Weike Technology, Nengke Technology, Hehe Information, and Maixinlin for potential investment opportunities [57][58].

Investment Rating - The report maintains a "Buy" rating for the following companies: Weike Technology (301196.SZ), Nengke Technology (603859.SH), Hehe Information (688615.SH), and Maixinlin (688685.SH) [9][59]. Core Insights - The AI agent platform Moltbook has sparked significant industry interest, attracting over 1.5 million AI agents within days of its launch, indicating a strong growth potential for agent networks and associated infrastructure needs [3][23]. - DeepSeek-OCR2 has introduced a groundbreaking "causal flow" reasoning mechanism, significantly enhancing visual language understanding and achieving state-of-the-art results in benchmark tests [33][41]. - Poetiq has successfully completed a $45.8 million seed round, aiming to optimize LLM capabilities and cost efficiency, showcasing a shift towards more efficient AI solutions [45][46]. Summary by Sections Computing Power Dynamics - The rental prices for computing power remain stable, with notable configurations such as Tencent Cloud's A100-40G priced at 28.64 CNY/hour and Alibaba Cloud's A100-80G at 31.58 CNY/hour [21][22]. - The launch of Moltbook has led to a surge in agent network activity, with over 150,000 posts and 230,000 comments generated by AI agents discussing various technical topics [23][30]. AI Application Dynamics - Kimi's weekly traffic increased by 40.89%, making it the fastest-growing AI application in terms of user engagement [31][32]. - DeepSeek-OCR2's innovative architecture allows for dynamic understanding of visual content, achieving a 3.73% improvement in benchmark scores compared to its predecessor [41][43]. AI Financing Trends - Poetiq's seed funding will be utilized to advance its core technology, which allows for efficient problem-solving with minimal training data, marking a significant advancement in LLM optimization [45][46]. Investment Recommendations - The report emphasizes the importance of investing in AI hardware and applications, particularly in companies like Weike Technology, Nengke Technology, Hehe Information, and Maixinlin, which are positioned to benefit from the growing demand for AI infrastructure [58][59].

责任编辑：小浪快报 截至10月31日，迈信林股东户数6170.00，较上期减少11.53%；人均流通股23569股，较上期增加 13.03%。2025年1月-9月，迈信林实现营业收入4.46亿元，同比增长48.42%；归母净利润5634.37万元， 同比增长55.17%。 分红方面，迈信林A股上市后累计派现6500.57万元。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 1月29日，迈信林跌2.64%，成交额1.28亿元。两融数据显示，当日迈信林获融资买入额1159.71万元， 融资偿还1593.24万元，融资净买入-433.53万元。截至1月29日，迈信林融资融券余额合计5.41亿元。 融资方面，迈信林当日融资买入1159.71万元。当前融资余额5.40亿元，占流通市值的7.01%，融资余额 超过近一年50%分位水平，处于较高位。 融券方面，迈信林1月29日融券偿还0.00股，融券卖出200.00股，按当日收盘价计算，卖出金额1 ...

Group 1 - The company appointed Mr. Wang Chengbiao as the secretary of the board, effective from the date of the board meeting on January 9, 2026, until the end of the current board's term [1] - Mr. Wang Chengbiao had not obtained the required training certification at the time of his appointment, and Mr. Xue Hui was designated to perform the duties of the secretary until Mr. Wang completed the training [1] - Mr. Wang Chengbiao has since completed the training for the position of board secretary and is now officially fulfilling his responsibilities [2] Group 2 - The contact information for Mr. Wang Chengbiao is provided, including phone number, fax number, email address, and office address [3]

深圳商报首席记者刘琼 "未来的影像终端不再是记录工具，而是具备生成能力的AI原生物种——即'新质影像'。"刘战国强调， 对宝安而言，与其在传统内容的红海中艰难突围，不如利用强大的硬件基因，直接切入AI影像终端这 一新赛道。当下的主要矛盾不是硬件与内容的失衡，而是传统智能终端向AI化新质终端升级的速度之 争。 如何实现价值链攀升？刘战国以影石为例给出答案：利用宝安极致的制造与配套能力，嫁接新技术，定 义新产品，诞生新品牌。他表示，AI革命为硬件创新提供了"洗牌期"，新一轮革命必将催生大批创新新 势力。 "宝安的下一个目标，是成为全球'新质影像'定义的策源地。"刘战国强调，宝安不必留恋过往的制造荣 光，而要前瞻未来的创新机会。通过政策引导与生态构建，推动企业从"制造"转向"智造"、从"代工"转 向"品牌"，在AI时代完成电子信息产业的华丽转身。 "宝安要实现从'智能影像'向'新质影像'的代际跨越。"谈及宝安影像产业的升级路径，深圳清华大学研 究院产业规划研究中心主任刘战国直言，审视这一集群不能止步于"补短板"，更需在AI浪潮下"锻长 板"。 在刘战国看来，外界对宝安电子信息产业的印象长期停留在"大而全"，却鲜少触 ...

Core Insights - Shenzhen is rapidly developing a "new quality imaging" industry chain, with over 500 companies participating in the recent "Baoying Smart Sharing" conference, showcasing technological advancements and policy implementations [2][3] Industry Overview - The "new quality imaging industry" is defined as a new digital resource industry driven by next-generation imaging devices and AI technologies, integrating artistic expression, technological innovation, and cultural value [3] - Shenzhen has established a trillion-level industrial cluster in ultra-high-definition display and smart terminals, with a global market share of over 92% in panoramic cameras [4] Key Players and Market Dynamics - Leading companies such as Yingshi Innovation and DJI are at the forefront, supported by a collaborative ecosystem of small and medium enterprises, creating a robust supply chain [4] - In Bao'an District, Yingshi Innovation leads the panoramic camera market with an 85.8% global market share, while Zhouming Technology dominates the XR virtual shooting sector with a 70% share [4] Government and Policy Support - The Shenzhen government has designated specific areas for software industry concentration, enhancing the "soft and hard collaboration" advantage in Bao'an [5] - The first national special support policy for the new quality imaging industry was launched at the conference, addressing key challenges in talent and funding [5] Future Prospects - Despite challenges such as a talent gap and reliance on core components, Shenzhen is leveraging its manufacturing cluster and cultural-tech integration to strengthen its market position [6] - The "Shenzhen imaging chain" aims to evolve from a source of innovation to a leading area, focusing on platform development, resource aggregation, and transformation facilitation [6]

证券代码：688685 证券简称：迈信林 公告编号：2026-005 特此公告。 联系电话：0512-66580868 传真号码：0512-66313263 电子信箱：maixinlin@maixinlin.com 办公地址：江苏省苏州市吴中区太湖街道溪虹路1009号 江苏迈信林航空科技股份有限公司董事会 2026年1月30日 江苏迈信林航空科技股份有限公司（以下简称"公司"）于2026年1月9日召 开第三届董事会第二十次会议，审议通过了《关于聘任公司董事会秘书的议案》， 经公司董事会提名委员会资格审核通过后，同意聘任王成标先生为公司第三届董 事会的董事会秘书，任期自本次董事会审议通过之日起至第三届董事会任期届满 之日止。鉴于聘任时，王成标先生尚未取得科创板董事会秘书任职培训证明，董 事会指定薛晖先生代行董事会秘书职责，待王成标先生取得科创板董事会秘书任 职培训证明后，正式履行董事会秘书职责。具体内容详见2026年1月10日公司在 在上海证券交易所网站（www.sse.com.cn）披露的《江苏迈信林航空科技股份有 限公司关于董事及董事会秘书辞职、补选董事及聘任董事会秘书暨调整专门委员 会委员的公告》（公告编 ...

Core Viewpoint - The company emphasizes its focus on core business and product innovation to enhance intrinsic investment value and create long-term value for shareholders [1] Group 1: Market Position and Strategy - The company's stock price fluctuations are influenced by market sentiment, industry changes, company conditions, and macroeconomic factors [1] - The company has achieved significant competitive advantages in the imaging technology sector through deep accumulation and continuous innovation [1] Group 2: Future Plans - The company plans to continue deepening its efforts in the intelligent imaging field by implementing technology innovation strategies, product planning strategies, and global brand strategies [1] - The goal is to further enhance the company's sustainable operational capabilities and overall competitiveness [1]